Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

During the Trading Day
37.50 -1.53 / -3.92%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
37.49 -0.0075 / -0.02%
Volume: 9.8K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Revenue and IncomeNet Revenues41.9M41.7M32.1M47.7M
Depreciation And Amortization499.0K172.0K221.0K352.0K
Operating ExpensesGross Income----------
General Expenses16.1M20.2M22.8M28.4M
Research And Development11.5M15.1M16.8M18.7M
Total Operating Expenses16.6M20.4M23.0M28.8M
Non-Operating ExpensesOperating Income25.3M21.3M9.0M19.0M
Extraordinary Credit670.0K0.00----
Extraordinary Charge-686.0K-8.0K---166.0K
Interest Expense On Debt3.2M0.0031.0K18.0K
Other Expenses1.1M0.00381.0K0.00
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income23.3M21.4M9.6M19.3M
Income Taxes0.000.000.00-15.2M
Preferred Dividend0.000.00-2.5M0.00
Net Income1.6M1.4M-4.0M34.4M
Shares To Calculate EPSShares To Calculate EPS16.8M16.8M9.8M18.4M
Shares To Calculate EPS Diluted16.8M16.8M9.8M19.2M
Earnings Per ShareEPS$1.32$1.13-$0.67$1.80
EPS Diluted$0.15$0.17-$0.67$1.80